Cargando…
Desmoglein 2 mutant mice develop cardiac fibrosis and dilation
Desmosomes are cell–cell adhesion sites and part of the intercalated discs, which couple adjacent cardiomyocytes. The connection is formed by the extracellular domains of desmosomal cadherins that are also linked to the cytoskeleton on the cytoplasmic side. To examine the contribution of the desmoso...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105238/ https://www.ncbi.nlm.nih.gov/pubmed/21455723 http://dx.doi.org/10.1007/s00395-011-0175-y |
_version_ | 1782204694375956480 |
---|---|
author | Krusche, Claudia A. Holthöfer, Bastian Hofe, Valérie van de Sandt, Annette M. Eshkind, Leonid Bockamp, Ernesto Merx, Marc W. Kant, Sebastian Windoffer, Reinhard Leube, Rudolf E. |
author_facet | Krusche, Claudia A. Holthöfer, Bastian Hofe, Valérie van de Sandt, Annette M. Eshkind, Leonid Bockamp, Ernesto Merx, Marc W. Kant, Sebastian Windoffer, Reinhard Leube, Rudolf E. |
author_sort | Krusche, Claudia A. |
collection | PubMed |
description | Desmosomes are cell–cell adhesion sites and part of the intercalated discs, which couple adjacent cardiomyocytes. The connection is formed by the extracellular domains of desmosomal cadherins that are also linked to the cytoskeleton on the cytoplasmic side. To examine the contribution of the desmosomal cadherin desmoglein 2 to cardiomyocyte adhesion and cardiac function, mutant mice were prepared lacking a part of the extracellular adhesive domain of desmoglein 2. Most live born mutant mice presented normal overall cardiac morphology at 2 weeks. Some animals, however, displayed extensive fibrotic lesions. Later on, mutants developed ventricular dilation leading to cardiac insufficiency and eventually premature death. Upon histological examination, cardiomyocyte death by calcifying necrosis and replacement by fibrous tissue were observed. Fibrotic lesions were highly proliferative in 2-week-old mutants, whereas the fibrotic lesions of older mutants showed little proliferation indicating the completion of local muscle replacement by scar tissue. Disease progression correlated with increased mRNA expression of c-myc, ANF, BNF, CTGF and GDF15, which are markers for cardiac stress, remodeling and heart failure. Taken together, the desmoglein 2-mutant mice display features of dilative cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, an inherited human heart disease with pronounced fibrosis and ventricular arrhythmias that has been linked to mutations in desmosomal proteins including desmoglein 2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0175-y) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-3105238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-31052382011-07-14 Desmoglein 2 mutant mice develop cardiac fibrosis and dilation Krusche, Claudia A. Holthöfer, Bastian Hofe, Valérie van de Sandt, Annette M. Eshkind, Leonid Bockamp, Ernesto Merx, Marc W. Kant, Sebastian Windoffer, Reinhard Leube, Rudolf E. Basic Res Cardiol Original Contribution Desmosomes are cell–cell adhesion sites and part of the intercalated discs, which couple adjacent cardiomyocytes. The connection is formed by the extracellular domains of desmosomal cadherins that are also linked to the cytoskeleton on the cytoplasmic side. To examine the contribution of the desmosomal cadherin desmoglein 2 to cardiomyocyte adhesion and cardiac function, mutant mice were prepared lacking a part of the extracellular adhesive domain of desmoglein 2. Most live born mutant mice presented normal overall cardiac morphology at 2 weeks. Some animals, however, displayed extensive fibrotic lesions. Later on, mutants developed ventricular dilation leading to cardiac insufficiency and eventually premature death. Upon histological examination, cardiomyocyte death by calcifying necrosis and replacement by fibrous tissue were observed. Fibrotic lesions were highly proliferative in 2-week-old mutants, whereas the fibrotic lesions of older mutants showed little proliferation indicating the completion of local muscle replacement by scar tissue. Disease progression correlated with increased mRNA expression of c-myc, ANF, BNF, CTGF and GDF15, which are markers for cardiac stress, remodeling and heart failure. Taken together, the desmoglein 2-mutant mice display features of dilative cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, an inherited human heart disease with pronounced fibrosis and ventricular arrhythmias that has been linked to mutations in desmosomal proteins including desmoglein 2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0175-y) contains supplementary material, which is available to authorized users. Springer-Verlag 2011-04-01 2011-07 /pmc/articles/PMC3105238/ /pubmed/21455723 http://dx.doi.org/10.1007/s00395-011-0175-y Text en © Springer-Verlag 2011 |
spellingShingle | Original Contribution Krusche, Claudia A. Holthöfer, Bastian Hofe, Valérie van de Sandt, Annette M. Eshkind, Leonid Bockamp, Ernesto Merx, Marc W. Kant, Sebastian Windoffer, Reinhard Leube, Rudolf E. Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title_full | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title_fullStr | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title_full_unstemmed | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title_short | Desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
title_sort | desmoglein 2 mutant mice develop cardiac fibrosis and dilation |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105238/ https://www.ncbi.nlm.nih.gov/pubmed/21455723 http://dx.doi.org/10.1007/s00395-011-0175-y |
work_keys_str_mv | AT kruscheclaudiaa desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT holthoferbastian desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT hofevalerie desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT vandesandtannettem desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT eshkindleonid desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT bockampernesto desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT merxmarcw desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT kantsebastian desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT windofferreinhard desmoglein2mutantmicedevelopcardiacfibrosisanddilation AT leuberudolfe desmoglein2mutantmicedevelopcardiacfibrosisanddilation |